Skip to main content

Table 3 Study objectives and outcomes

From: Protocol for a single-arm, pilot trial of creatine monohydrate supplementation in patients with Alzheimer’s disease

Objective

Measurement

Timepoint

Aim 1: Feasibility

Recruitment and retention

Throughout study

 

Self-reported compliance on Cr supplement calendar

Throughout intervention

 

Serum creatine (Cr) levels

Baseline, 4 weeks, and 8 weeks

Aim 2: Brain creatine concentration

Magnetic resonance spectroscopy measurement of brain total creatine (Cr)

Baseline and 8 weeks

Aim 3: Cognition

NIH-Toolbox® Cognitive Battery

Baseline and 8 weeks

Aim 4: Peripheral mitochondrial function

OROBOROS Oxygraph-2 K measurement of platelet and lymphocyte respiration, ATP production, and ROS production

Baseline and 8 weeks

Aim 4: Brain mitochondrial function

Magnetic resonance spectroscopy measurement of brain N-acetylaspartate (NAA) and glutathione (GSH)

Baseline and 8 weeks

Aim 5: Muscle strength and morphology

Handgrip strength, leg extensor strength, and quadriceps ultrasound

Baseline and 8 weeks